Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The genomic regulation of metastatic dormancy. | Cancer Metastasis Rev | 2023 | 36600151 | PubTator, text mining | PubMed |
| Integrated network pharmacology and experimental validation to explore the mechanisms underlying naringenin treatment of chronic wounds. | Sci Rep | 2023 | 36599852 | PubTator, text mining | PubMed |
| Pre exposure to enriched environment alleviates brain injury after ischemia-reperfusion by inhibiting p38MAPK/STAT1 pathway. | Mol Biol Rep | 2023 | 36572761 | PubTator, text mining | PubMed |
| The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-Raf and MAPK signaling cascade. | Oncogene | 2023 | 36564468 | PubTator, text mining | PubMed |
| Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36481486 | PubTator, text mining | PubMed |
| Neuroprotective and anticancer effects of 7‑Methoxyheptaphylline via the TAK1 pathway. | Oncol Rep | 2023 | 36416312 | PubTator, text mining | PubMed |
| P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection. | J Exp Med | 2023 | 36315050 | PubTator, text mining | PubMed |
| Alcohol and breast cancer. | Pharmacol Rep | 2023 | 36310188 | PubTator, text mining | PubMed |
| Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines. | Front Pharmacol | 2022 | 36618910 | PubTator, text mining | PubMed |
| The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect? | Cells | 2022 | 36611944 | PubTator, text mining | PubMed |
| Sympathetic nerve infiltration promotes stomach adenocarcinoma progression via norepinephrine/β2-adrenoceptor/YKL-40 signaling pathway. | Heliyon | 2022 | 36593854 | PubTator, text mining | PubMed |
| Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban. | Hum Genomics | 2022 | 36578040 | PubTator, text mining | PubMed |
| The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells. | NPJ Precis Oncol | 2022 | 36575215 | PubTator, text mining | PubMed |
| Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. | Oxid Med Cell Longev | 2022 | 36561981 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer. | Front Cell Dev Biol | 2022 | 36531950 | PubTator, text mining | PubMed |
| Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. | Front Immunol | 2022 | 36524125 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity. | Dis Model Mech | 2022 | 36518084 | PubTator, text mining | PubMed |
| Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations. | Front Pharmacol | 2022 | 36506508 | PubTator, text mining | PubMed |
| Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives. | Front Endocrinol (Lausanne) | 2022 | 36506068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=13